quest diagnostics 6_25Jefferies6_26_07

This document provides an overview of Quest Diagnostics and its strategy presented at a healthcare conference. It summarizes that Quest is the leader in diagnostic testing in the US, serving over 150 million patients annually. It has recently acquired AmeriPath to strengthen its cancer diagnostics and expand its esoteric and hospital testing. The acquisition improves Quest's revenue mix toward higher-margin specialized services.